1. Anticoagulant-induced bleeding biggest safety issue of 2012

   Review 16 November 2013 Pages: 1 - 1

2. Need to monitor plasma TCA levels in patients at risk of seizures

   Incidence study 16 November 2013 Pages: 2 - 2

3. AE reporting patterns changing, analysis challenges Weber effect

   Incidence study 16 November 2013 Pages: 2 - 2

4. Everolimus, Resolute zotarolimus stents rank safest

   Review 16 November 2013 Pages: 2 - 2

5. Aspirin lacks efficacy in primary prevention of CVD, cancer

   Review 16 November 2013 Pages: 3 - 3

6. Mild infections common with TNF-α use in paediatic patients

   Review 16 November 2013 Pages: 3 - 3

7. Severe hypotension in association with tamsulosin in men with BPH

   Epidemiology population study 16 November 2013 Pages: 3 - 3

8. PRO guidance aims to better the capture of `real-world' safety data

   Guideline 16 November 2013 Pages: 4 - 4

9. FDA proposes faster safety info updates for generics

   News item 16 November 2013 Pages: 4 - 4

10. Updated safety recommendations for enoxaparin

    News item 16 November 2013 Pages: 4 - 4

11. EMA reviews use of valproate during pregnancy

    News item 16 November 2013 Pages: 4 - 4

12. Amikacin overdose

    Case report 16 November 2013 Pages: 5 - 5

13. Albendazole

    Case report 16 November 2013 Pages: 5 - 5

14. Adalimumab/etanercept

    Case report 16 November 2013 Pages: 5 - 5

15. Adalimumab/etanercept

    Case report 16 November 2013 Pages: 5 - 5

16. Amiodarone

    Case report 16 November 2013 Pages: 6 - 6

17. Amikacin/ceftriaxone

    Case report 16 November 2013 Pages: 6 - 6

18. Amiodarone

    Case report 16 November 2013 Pages: 6 - 6

19. Amlodipine/zolpidem overdose

    Case report 16 November 2013 Pages: 6 - 6

20. Amygdalin

    Case report 16 November 2013 Pages: 7 - 7

21. Antineoplastics

    Case report 16 November 2013 Pages: 7 - 7

22. Amoxicillin/rifamycin

    Case report 16 November 2013 Pages: 7 - 7

23. Antineoplastics

    Case report 16 November 2013 Pages: 8 - 8

24. Antineoplastics

    Case report 16 November 2013 Pages: 8 - 8

25. Antineoplastics

    Case report 16 November 2013 Pages: 8 - 8

26. Antineoplastics/immunosuppressants

    Case report 16 November 2013 Pages: 8 - 8

27. Antivenin naja

    Case report 16 November 2013 Pages: 9 - 9

28. BCG vaccine

    Case report 16 November 2013 Pages: 9 - 9

29. Baclofen

    Case report 16 November 2013 Pages: 9 - 9

30. Aspirin/flurbiprofen

    Case report 16 November 2013 Pages: 9 - 9

31. Betamethasone/nifedipine

    Case report 16 November 2013 Pages: 10 - 10

32. Benzocaine

    Case report 16 November 2013 Pages: 10 - 10

33. Benzodiazepines/escitalopram/paroxetine

    Case report 16 November 2013 Pages: 10 - 10

34. Bevacizumab/paclitaxel

    Case report 16 November 2013 Pages: 10 - 10

35. Bevacizumab

    Case report 16 November 2013 Pages: 10 - 10

36. Botulinum toxin A/lidocaine/epinephrine interaction

    Case report 16 November 2013 Pages: 11 - 11

37. Bleomycin

    Case report 16 November 2013 Pages: 11 - 11

38. Bromazepam/diazepam/verapamil overdose

    Case report 16 November 2013 Pages: 11 - 11

39. Caffeine overdose

    Case report 16 November 2013 Pages: 12 - 12

40. Bupivacaine/fentanyl

    Case report 16 November 2013 Pages: 12 - 12

41. Bupivacaine

    Case report 16 November 2013 Pages: 12 - 12

42. Capsaicin/treprostinil

    Case report 16 November 2013 Pages: 12 - 12

43. Bupropion/lipid emulsion

    Case report 16 November 2013 Pages: 12 - 12

44. Carbamazepine

    Case report 16 November 2013 Pages: 13 - 13

45. Carbamazepine/levetiracetam overdose

    Case report 16 November 2013 Pages: 13 - 13

46. Carbamazepine

    Case report 16 November 2013 Pages: 13 - 13

47. Chlorhexidine

    Case report 16 November 2013 Pages: 14 - 14

48. Carboplatin/docetaxel

    Case report 16 November 2013 Pages: 14 - 14

49. Ceftaroline fosamil

    Case report 16 November 2013 Pages: 14 - 14

50. Ceftriaxone

    Case report 16 November 2013 Pages: 14 - 14